atropine has been researched along with End Stage Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aqel, B; McCully, R; Olson, N; Pellikka, P; Shipman, J; Snipelisky, D; Watt, K | 1 |
1 other study(ies) available for atropine and End Stage Liver Disease
Article | Year |
---|---|
Low to Intermediate Dose Atropine Administration During Dobutamine Stress Echocardiography in the Pre-Liver Transplant Population.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atropine; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Echocardiography, Stress; End Stage Liver Disease; Female; Humans; Liver Transplantation; Male; Middle Aged; Preoperative Care; Prospective Studies | 2018 |